Maria Charlotte Fribert
Chief Executive Officer at TOLERANZIA AB
Profile
Maria Charlotte Fribert is the founder of Epixis SA. She is currently the Chief Executive Officer at Toleranzia AB since 2016.
Previously, she worked at AstraZeneca R&D Mölndal as a Project Director-Drug Development.
Dr. Fribert holds a doctorate degree from Université Pierre et Marie Curie.
Maria Charlotte Fribert active positions
| Companies | Position | Start |
|---|---|---|
| TOLERANZIA AB | Chief Executive Officer | 2016-04-10 |
Former positions of Maria Charlotte Fribert
| Companies | Position | End |
|---|---|---|
Epixis SA
 Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Founder | - |
| AstraZeneca R&D Mölndal | Corporate Officer/Principal | - |
Training of Maria Charlotte Fribert
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TOLERANZIA AB | Health Technology |
| Private companies | 3 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
Epixis SA
Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Health Technology |
| AstraZeneca R&D Mölndal |
- Stock Market
- Insiders
- Maria Charlotte Fribert
